COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1539: Articles 15381-15390  | Next

Household transmission of SARS-CoV-2 from humans to dogs in Washington and Idaho: burden and risk factors
Meisner, J., Baszler, T., Kuehl, K., Ramirez, V., Baines, A., Frisbie, L., Lofgren, E., DeAvila, D., Wolking, R., Bradway, D., Rabinowitz, P.
10.1101/2021.04.24.440952 — Posted: 2021-04-26
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
Jette, C. A., Cohen, A. A., Gnanapragasam, P. N. P., Muecksch, F., Lee, Y. E., Huey-Tubman, K. E., Schmidt, F., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., West, A. P., Keeffe, J. R., Bjorkman, P., Barnes, C. O.
10.1101/2021.04.23.441195 — Posted: 2021-04-26
A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques
Harris, P., Brasel, T., Massey, C., Herst, C., Burkholz, S., Lloyd, P., Blankenberg, T., Bey, T., Carback, R., Hodge, T., Ciotlos, S., Wang, L., Comer, J. E., Rubsamen, R. M.
10.1101/2021.04.24.441228 — Posted: 2021-04-26
Autoantibodies against Progranulin and IL-1 receptor antagonist in critically ill COVID-19
Thurner, L., Fadle, N., Bewarder, M., Kos, I., Regitz, E., Cetin, O., Thurner, B., Fischer, Y., Rixecker, T., Preuss, K.-D., Schormann, C., Neumann, F., Hartmann, S., Bock, T., Kaddu-Mulindwa, D., Bette, B., Bittenbring, J. T., Christofyllakis, K., Bick, A., Lesan, V., Abdi, Z., Mang, S., Becker, A., Metz, C., Seiler, F., Lehmann, J., Agne, P., Adams, T., Link, A., Werner, C., Thiel-Bodenstaff, A., Reichert, M., Danziger, G., Papan, C., Pilch, J., Pfuhl, T., Wuchter, P., Herr, C., Lohse, S., Schrezenmeier, H., Boehm, M., Langer, F., Gaebelein, G., Friesenhahn-Ochs, B., Bals, R., Lammert, F., Koerper, S., Rissland, J., Lensch, C., Stilgenbauer, S., Becker, S. L., Smola, S., Krawczyk, M., Lepper, P.
10.1101/2021.04.23.441188 — Posted: 2021-04-26
Binding mechanism of neutralizing Nanobodies targeting SARS-CoV-2 Spike Glycoprotein
Golcuk, M., Hacisuleyman, A., Erman, B., Yildiz, A., Gur, M.
10.1101/2021.04.23.441186 — Posted: 2021-04-26
Safety and efficacy of Pulmonary physiotherapy in hospitalized patients with severe COVID-19 pneumonia (PPTCOVID): A prospective, randomised, single-blind, controlled trial
Javaherian, M., Shadmehr, A., Keshtkar, A., Beigmohammadi, M. T., Dabbaghipour, N., Syed, A., Attarbashi Moghaddam, B.
10.1101/2021.04.24.21255892 — Posted: 2021-04-25
Point of Care Testing using rapid automated Antigen Testing for SARS-COV-2 in Care Homes; an exploratory safety, usability and diagnostic agreement evaluation
Micocci, M., Buckle, P., Hayward, G., Allen, A. J., Davies, K., Kierkegaard, P., Spilsbury, K., Thompson, C., Castle, A., Heath, R., Sharpe, C., Akrill, C., Lasserson, D., Perera, R., Body, R., Gordon, A. L.
10.1101/2021.04.22.21255948 — Posted: 2021-04-25
Learning from the resilience of hospitals and their staff to the COVID-19 pandemic: a scoping review.
Traverson, L., Stennett, J., Mathevet, I., Correia Paes Zacarias, A., Paz de Sousa, K., Andrade, A., Zinszer, K., Ridde, V.
10.1101/2021.04.22.21255908 — Posted: 2021-04-25
Efficacy of universal masking for source control and personal protection from simulated cough and exhaled aerosols in a room
Lindsley, W. G., Beezhold, D. H., Derk, R. C., Coyle, J., Blachere, F. M., Boots, T., Reynolds, J. S., McKinney, W. G., Sinsel, E., Noti, J. D.
10.1101/2021.04.21.21255880 — Posted: 2021-04-25
Effects of the COVID-19 Pandemic on Park Use in U.S. Cities
Jay, J., Heykoop, F., Hwang, L., de Jong, J., Kondo, M.
10.1101/2021.04.23.21256007 — Posted: 2021-04-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).